Coronavirus Update: BARDA Funding Rises To $955m As Moderna Expands Phase III Trial

30,000 Recruitment Target For All US-Sponsored Trials

Moderna has updated its protocol, expanding its recruitment target to 30,000 and aiming for more ethnically diverse and at-risk groups to be included. 

Moderna_Pills_Syringe
Moderna has said the first millions of doses of its vaccine could be ready for Thanksgiving in late November.

The US government is to double its funding of Moderna, Inc.’s COVID-19 vaccine research, to just short of $1 billion dollars after the biotech decided to expand its Phase III program.

The US agency the

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from COVID-19

More from Scrip